Manual counting requires precisely measure Ki67 positive cells in as many as 1,000 cancer cells from at least 3 high-power fields at the invasive edge, which is the most frequently used method in clinical practice as recommended by the International Ki67 in Breast Cancer Working Group9. This evidence concerns the gene MKI67 and breast carcinoma.